ImpactRx, a provider of consultative analytical models, has appointed Gregory Ellis as president and chief executive officer (CEO).
Subscribe to our email newsletter
Ellis will expand ImpactRx through its next phase of growth including the expansion of its Consulting Analytics business, which is fueled by the company’s proprietary ImpactData.
From 2002 to July 2011 Ellis worked at Rosetta as a senior partner and served in a variety of leadership roles, helping the firm grow from $5m to $24m in annual revenue over a nine year period.
Ellis has served in the information, analysis and consulting industry including DRI, IRI, Nielsen and Opinion Research Corporation.
Ellis at IRI and Nielsen was at the forefront of leveraging scanner store and household panel data to improve pricing and promotion effectiveness.
ImpactRx president and CEO Gregory Ellis said he is delighted to be joining ImpactRx at this point in the company’s development and he is looking forward to work with its people and data assets to supply even greater insight to their clients.
"The company’s iPhone-enabled longitudinal physician research model is unique and I’m eager to take the customer value it delivers to new levels," Ellis said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.